vs

Side-by-side financial comparison of ARTS WAY MANUFACTURING CO INC (ARTW) and cbdMD, Inc. (YCBD). Click either name above to swap in a different company.

ARTS WAY MANUFACTURING CO INC is the larger business by last-quarter revenue ($5.1M vs $5.0M, roughly 1.0× cbdMD, Inc.). cbdMD, Inc. runs the higher net margin — -5.6% vs -12.7%, a 7.1% gap on every dollar of revenue. On growth, cbdMD, Inc. posted the faster year-over-year revenue change (-1.9% vs -17.9%). cbdMD, Inc. produced more free cash flow last quarter ($-977.3K vs $-1.0M). Over the past eight quarters, cbdMD, Inc.'s revenue compounded faster (7.1% CAGR vs -5.9%).

Art's Way Manufacturing is an American producer of agricultural machinery, modular buildings and cutting tools under the brand names Art's Way, Art's Way Scientific and American Carbide Tool. The firm previously manufactured OEM feed blowers sold by Case New Holland.

cbdMD, Inc. is a U.S.-based consumer wellness company that manufactures and distributes hemp-derived CBD products, including tinctures, topicals, gummies, pet care items, and bath products. All offerings undergo third-party quality testing, and are sold via e-commerce platforms, brick-and-mortar retail stores, and wellness partner channels primarily across the United States.

ARTW vs YCBD — Head-to-Head

Bigger by revenue
ARTW
ARTW
1.0× larger
ARTW
$5.1M
$5.0M
YCBD
Growing faster (revenue YoY)
YCBD
YCBD
+16.0% gap
YCBD
-1.9%
-17.9%
ARTW
Higher net margin
YCBD
YCBD
7.1% more per $
YCBD
-5.6%
-12.7%
ARTW
More free cash flow
YCBD
YCBD
$64.7K more FCF
YCBD
$-977.3K
$-1.0M
ARTW
Faster 2-yr revenue CAGR
YCBD
YCBD
Annualised
YCBD
7.1%
-5.9%
ARTW

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ARTW
ARTW
YCBD
YCBD
Revenue
$5.1M
$5.0M
Net Profit
$-645.5K
$-283.1K
Gross Margin
18.6%
59.8%
Operating Margin
-11.2%
-5.7%
Net Margin
-12.7%
-5.6%
Revenue YoY
-17.9%
-1.9%
Net Profit YoY
-177.6%
-1975.7%
EPS (diluted)
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARTW
ARTW
YCBD
YCBD
Q4 25
$5.1M
$5.0M
Q3 25
$6.4M
$4.7M
Q2 25
$6.3M
$4.6M
Q1 25
$5.1M
$4.7M
Q4 24
$6.2M
$5.1M
Q3 24
$5.9M
$4.6M
Q2 24
$6.7M
$5.2M
Q1 24
$5.7M
$4.4M
Net Profit
ARTW
ARTW
YCBD
YCBD
Q4 25
$-645.5K
$-283.1K
Q3 25
$254.1K
$-680.0K
Q2 25
$1.5M
$-895.3K
Q1 25
$-55.8K
$-480.8K
Q4 24
$832.0K
$15.1K
Q3 24
$-26.2K
$-152.8K
Q2 24
$-33.3K
$459.7K
Q1 24
$-465.0K
$-3.0M
Gross Margin
ARTW
ARTW
YCBD
YCBD
Q4 25
18.6%
59.8%
Q3 25
27.5%
58.8%
Q2 25
32.5%
61.5%
Q1 25
29.1%
62.3%
Q4 24
36.1%
66.5%
Q3 24
28.9%
53.9%
Q2 24
28.3%
65.8%
Q1 24
25.7%
59.0%
Operating Margin
ARTW
ARTW
YCBD
YCBD
Q4 25
-11.2%
-5.7%
Q3 25
5.4%
-14.5%
Q2 25
8.1%
-19.6%
Q1 25
0.0%
-10.2%
Q4 24
8.4%
-1.7%
Q3 24
2.6%
-6.9%
Q2 24
2.5%
-7.4%
Q1 24
-6.6%
-35.4%
Net Margin
ARTW
ARTW
YCBD
YCBD
Q4 25
-12.7%
-5.6%
Q3 25
4.0%
-14.4%
Q2 25
23.4%
-19.4%
Q1 25
-1.1%
-10.1%
Q4 24
13.5%
0.3%
Q3 24
-0.4%
-3.4%
Q2 24
-0.5%
8.9%
Q1 24
-8.1%
-68.8%
EPS (diluted)
ARTW
ARTW
YCBD
YCBD
Q4 25
$-0.13
Q3 25
$0.05
Q2 25
$0.29
Q1 25
$-0.01
Q4 24
$0.17
Q3 24
$-0.01
Q2 24
$-0.01
$-0.15
Q1 24
$-0.09
$-1.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARTW
ARTW
YCBD
YCBD
Cash + ST InvestmentsLiquidity on hand
$4.8K
$3.4M
Total DebtLower is stronger
$2.5M
Stockholders' EquityBook value
$13.3M
$9.0M
Total Assets
$22.5M
$11.8M
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARTW
ARTW
YCBD
YCBD
Q4 25
$4.8K
$3.4M
Q3 25
$6.0K
$2.3M
Q2 25
$4.5K
$1.1M
Q1 25
$4.1K
$1.8M
Q4 24
$1.9K
$2.0M
Q3 24
$5.1K
$2.5M
Q2 24
$4.5K
$2.4M
Q1 24
$2.5K
$2.1M
Total Debt
ARTW
ARTW
YCBD
YCBD
Q4 25
$2.5M
Q3 25
Q2 25
Q1 25
Q4 24
$2.1M
Q3 24
$2.7M
Q2 24
$2.7M
Q1 24
$2.7M
Stockholders' Equity
ARTW
ARTW
YCBD
YCBD
Q4 25
$13.3M
$9.0M
Q3 25
$13.9M
$7.2M
Q2 25
$13.6M
$6.1M
Q1 25
$12.1M
$665.8K
Q4 24
$12.1M
$1.8M
Q3 24
$11.3M
$2.0M
Q2 24
$11.2M
$3.0M
Q1 24
$11.2M
$3.1M
Total Assets
ARTW
ARTW
YCBD
YCBD
Q4 25
$22.5M
$11.8M
Q3 25
$21.8M
$10.4M
Q2 25
$20.9M
$9.9M
Q1 25
$21.0M
$10.9M
Q4 24
$21.2M
$11.5M
Q3 24
$23.5M
$10.6M
Q2 24
$23.2M
$13.8M
Q1 24
$24.3M
$14.6M
Debt / Equity
ARTW
ARTW
YCBD
YCBD
Q4 25
0.19×
Q3 25
Q2 25
Q1 25
Q4 24
0.17×
Q3 24
0.24×
Q2 24
0.24×
Q1 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARTW
ARTW
YCBD
YCBD
Operating Cash FlowLast quarter
$-889.2K
$-812.5K
Free Cash FlowOCF − Capex
$-1.0M
$-977.3K
FCF MarginFCF / Revenue
-20.6%
-19.5%
Capex IntensityCapex / Revenue
3.0%
3.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-1.5M
$-2.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARTW
ARTW
YCBD
YCBD
Q4 25
$-889.2K
$-812.5K
Q3 25
$-1.3M
$-240.7K
Q2 25
$1.4M
$-704.2K
Q1 25
$-101.8K
$-189.5K
Q4 24
$1.2M
$-317.9K
Q3 24
$282.4K
$167.4K
Q2 24
$1.2M
$289.8K
Q1 24
$-99.3K
$-704.1K
Free Cash Flow
ARTW
ARTW
YCBD
YCBD
Q4 25
$-1.0M
$-977.3K
Q3 25
$-1.5M
$-243.6K
Q2 25
$1.2M
$-705.7K
Q1 25
$-184.5K
$-205.0K
Q4 24
$1.1M
$-482.3K
Q3 24
$180.5K
$157.4K
Q2 24
$1.0M
Q1 24
$-380.4K
$-708.7K
FCF Margin
ARTW
ARTW
YCBD
YCBD
Q4 25
-20.6%
-19.5%
Q3 25
-23.8%
-5.2%
Q2 25
19.3%
-15.3%
Q1 25
-3.6%
-4.3%
Q4 24
17.6%
-9.4%
Q3 24
3.1%
3.5%
Q2 24
15.1%
Q1 24
-6.6%
-16.2%
Capex Intensity
ARTW
ARTW
YCBD
YCBD
Q4 25
3.0%
3.3%
Q3 25
4.1%
0.1%
Q2 25
2.1%
0.0%
Q1 25
1.6%
0.3%
Q4 24
1.8%
3.2%
Q3 24
1.7%
0.2%
Q2 24
3.4%
0.0%
Q1 24
4.9%
0.1%
Cash Conversion
ARTW
ARTW
YCBD
YCBD
Q4 25
Q3 25
-4.99×
Q2 25
0.91×
Q1 25
Q4 24
1.44×
-21.06×
Q3 24
Q2 24
0.63×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARTW
ARTW

Agricultural Products$2.8M55%
Modular Buildings$2.2M44%

YCBD
YCBD

Sales Channel Directly To Consumer$3.6M72%
Sales Channel Through Intermediary$1.4M28%

Related Comparisons